Literature DB >> 26880475

Impact of Awareness and Patterns of Nonhospitalized Atrial Fibrillation on the Risk of Mortality: The Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study.

Wesley T O'Neal1, Jimmy T Efird2, Suzanne E Judd3, Leslie A McClure4, Virginia J Howard5, George Howard3, Elsayed Z Soliman6,7.   

Abstract

BACKGROUND: Although mortality associated with atrial fibrillation (AF) has been reported to decrease over prior decades, the mortality risk of asymptomatic, nonhospitalized AF has not been examined. HYPOTHESIS: Asymptomatic, nonhospitalized AF is associated with an increased risk of death.
METHODS: This analysis included 25,976 participants (mean age, 65 ± 9.4 years; 55% female; 38% black) from the Reasons for Geographic And Racial Differences (REGARDS) study. Atrial fibrillation was detected on the baseline electrocardiogram (ECG AF) or by self-reported history. Atrial fibrillation unawareness was defined as present if ECG evidence of the arrhythmia was detected but no self-reported history was reported. All-cause mortality was confirmed during follow-up through March 31, 2014.
RESULTS: A total of 2208 (8.5%) participants had AF at baseline (ECG: n = 371/17%; self-reported: n = 1837/83%). Over a median follow-up of 7.6 years, 3481 deaths occurred. In a multivariable Cox regression model, AF was associated with a 32% increased risk of mortality (95% confidence interval [CI]: 1.19-1.46). Risk of death was higher among those with ECG AF (hazard ratio: 1.71, 95% CI: 1.42-2.07) compared with self-reported cases (hazard ratio: 1.15, 95% CI: 1.03-1.29). Those who were unaware of their AF diagnosis had a 94% increased risk of death (95% CI: 1.50-2.52) compared with AF participants who were aware of their diagnosis.
CONCLUSIONS: Asymptomatic, nonhospitalized AF is associated with an increased risk of mortality in the general population. Mortality is higher in those with ECG-confirmed cases and among those who are unaware of their diagnosis.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 26880475      PMCID: PMC4769105          DOI: 10.1002/clc.22501

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  25 in total

1.  Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Authors:  Elsayed Z Soliman; George Howard; James F Meschia; Mary Cushman; Paul Muntner; Patrick M Pullicino; Leslie A McClure; Suzanne Judd; Virginia J Howard
Journal:  Stroke       Date:  2011-08-04       Impact factor: 7.914

2.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

3.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

4.  A linear rank test for use when the main interest is in differences in cure rates.

Authors:  R J Gray; A A Tsiatis
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

5.  Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation.

Authors:  Jonathan P Piccini; Moritz F Sinner; Melissa A Greiner; Bradley G Hammill; João D Fontes; James P Daubert; Patrick T Ellinor; Adrian F Hernandez; Allan J Walkey; Susan R Heckbert; Emelia J Benjamin; Lesley H Curtis
Journal:  Circulation       Date:  2012-09-26       Impact factor: 29.690

6.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

7.  Rate control and sinus rhythm maintenance in atrial fibrillation: national trends in medication use, 1980-1996.

Authors:  R S Stafford; D C Robson; B Misra; J Ruskin; D E Singer
Journal:  Arch Intern Med       Date:  1998-10-26

8.  Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study.

Authors:  Jan Heeringa; Jan A Kors; Albert Hofman; Frank J A van Rooij; Jacqueline C M Witteman
Journal:  Am Heart J       Date:  2008-10-14       Impact factor: 4.749

9.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

Authors:  A D Krahn; J Manfreda; R B Tate; F A Mathewson; T E Cuddy
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

10.  Grand challenge: understanding survival paradoxes in epidemiology.

Authors:  Jimmy T Efird; Wesley T O'Neal; Whitney L Kennedy; Alan P Kypson
Journal:  Front Public Health       Date:  2013-04-02
View more
  7 in total

1.  Racial/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States.

Authors:  Salina P Waddy; Allen J Solomon; Adan Z Becerra; Julia B Ward; Kevin E Chan; Chyng-Wen Fwu; Jenna M Norton; Paul W Eggers; Kevin C Abbott; Paul L Kimmel
Journal:  J Am Soc Nephrol       Date:  2020-02-20       Impact factor: 10.121

2.  Screening entire healthcare system ECG database: Association of deep terminal negativity of P wave in lead V1 and ECG referral with mortality.

Authors:  Allison Junell; Jason Thomas; Lauren Hawkins; Jiri Sklenar; Trevor Feldman; Charles A Henrikson; Larisa G Tereshchenko
Journal:  Int J Cardiol       Date:  2016-11-10       Impact factor: 4.164

Review 3.  Racial and Ethnic Considerations in Patients With Atrial Fibrillation: JACC Focus Seminar 5/9.

Authors:  Faye L Norby; Emelia J Benjamin; Alvaro Alonso; Sumeet S Chugh
Journal:  J Am Coll Cardiol       Date:  2021-12-21       Impact factor: 27.203

4.  Association of income and educational attainment in hospitalization events in atrial fibrillation.

Authors:  Tarryn Tertulien; Yimin Chen; Andrew D Althouse; Utibe R Essien; Amber Johnson; Jared W Magnani
Journal:  Am J Prev Cardiol       Date:  2021-06-01

5.  The appropriate use of risk scores in the prediction of atrial fibrillation.

Authors:  Wesley T O'Neal; Alvaro Alonso
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 6.  Biomarkers and the prediction of atrial fibrillation: state of the art.

Authors:  Wesley T O'Neal; Sanjay Venkatesh; Stephen T Broughton; William F Griffin; Elsayed Z Soliman
Journal:  Vasc Health Risk Manag       Date:  2016-07-18

7.  A cross-sectional analysis of racial differences in accelerated aging and cognitive function among patients with atrial fibrillation: The SAGE-AF study: Forrester, Accelerated aging and cognitive function.

Authors:  Sarah N Forrester; David D McManus; Jane S Saczynski; Isabelle C Pierre-Louis; Benita A Bamgbade; Catarina I Kiefe
Journal:  EClinicalMedicine       Date:  2021-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.